These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 8622889)
1. Delay in serum stimulation of Erk activity caused by oncogenic transformation. Greulich H; Reichman C; Hanafusa H Oncogene; 1996 Apr; 12(8):1689-95. PubMed ID: 8622889 [TBL] [Abstract][Full Text] [Related]
2. Repression of mitogen-activated protein kinases ERK1/ERK2 activity by a protein tyrosine phosphatase in rat fibroblasts transformed by upstream oncoproteins. Gopalbhai K; Meloche S J Cell Physiol; 1998 Jan; 174(1):35-47. PubMed ID: 9397154 [TBL] [Abstract][Full Text] [Related]
3. Suppression of growth factor-mediated MAP kinase activation by v-raf in macrophages: a putative role for the MKP-1 phosphatase. Krautwald S; Büscher D; Dent P; Ruthenberg K; Baccarini M Oncogene; 1995 Mar; 10(6):1187-92. PubMed ID: 7700643 [TBL] [Abstract][Full Text] [Related]
4. Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase. Groom LA; Sneddon AA; Alessi DR; Dowd S; Keyse SM EMBO J; 1996 Jul; 15(14):3621-32. PubMed ID: 8670865 [TBL] [Abstract][Full Text] [Related]
5. Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1. Ward Y; Gupta S; Jensen P; Wartmann M; Davis RJ; Kelly K Nature; 1994 Feb; 367(6464):651-4. PubMed ID: 8107850 [TBL] [Abstract][Full Text] [Related]
6. A role for Ras in v-Crk transformation. Greulich H; Hanafusa H Cell Growth Differ; 1996 Nov; 7(11):1443-51. PubMed ID: 8930393 [TBL] [Abstract][Full Text] [Related]
7. Mitogen-activated protein kinase and mitogen-activated kinase phosphatase-1 expression in the Noble rat model of sex hormone-induced prostatic dysplasia and carcinoma. Leav I; Galluzzi CM; Ziar J; Stork PJ; Ho SM; Loda M Lab Invest; 1996 Sep; 75(3):361-70. PubMed ID: 8804359 [TBL] [Abstract][Full Text] [Related]
8. Asbestos causes stimulation of the extracellular signal-regulated kinase 1 mitogen-activated protein kinase cascade after phosphorylation of the epidermal growth factor receptor. Zanella CL; Posada J; Tritton TR; Mossman BT Cancer Res; 1996 Dec; 56(23):5334-8. PubMed ID: 8968079 [TBL] [Abstract][Full Text] [Related]
9. Transformation-resistant mos revertant is unable to activate MAP kinase kinase in response to v-mos or v-raf. Topol LZ; Marx M; Calothy G; Blair DG Cell Growth Differ; 1995 Jan; 6(1):27-38. PubMed ID: 7718484 [TBL] [Abstract][Full Text] [Related]
10. Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation. Hutter D; Chen P; Barnes J; Liu Y Biochem J; 2000 Nov; 352 Pt 1(Pt 1):155-63. PubMed ID: 11062068 [TBL] [Abstract][Full Text] [Related]
11. Disruption of the erp/mkp-1 gene does not affect mouse development: normal MAP kinase activity in ERP/MKP-1-deficient fibroblasts. Dorfman K; Carrasco D; Gruda M; Ryan C; Lira SA; Bravo R Oncogene; 1996 Sep; 13(5):925-31. PubMed ID: 8806681 [TBL] [Abstract][Full Text] [Related]
12. Extracellular signal-regulated kinase-2, but not c-Jun NH2-terminal kinase, activation correlates with surface IgM-mediated apoptosis in the WEHI 231 B cell line. Lee JR; Koretzky GA J Immunol; 1998 Aug; 161(4):1637-44. PubMed ID: 9712025 [TBL] [Abstract][Full Text] [Related]
13. Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade. Lengyel E; Wang H; Gum R; Simon C; Wang Y; Boyd D Oncogene; 1997 May; 14(21):2563-73. PubMed ID: 9191056 [TBL] [Abstract][Full Text] [Related]
14. The mitogen-activated protein kinases, ERK1 and ERK2. Cobb MH; Hepler JE; Cheng M; Robbins D Semin Cancer Biol; 1994 Aug; 5(4):261-8. PubMed ID: 7803762 [TBL] [Abstract][Full Text] [Related]
15. Serotonergic repression of mitogen-activated protein kinase control of the calcitonin gene-related peptide enhancer. Durham PL; Russo AF Mol Endocrinol; 1998 Jul; 12(7):1002-9. PubMed ID: 9658404 [TBL] [Abstract][Full Text] [Related]
16. Ecdysone-inducible expression of oncogenic Ha-Ras in NIH 3T3 cells leads to transient nuclear localization of activated extracellular signal-regulated kinase regulated by mitogen-activated protein kinase phosphatase-1. Plows D; Briassouli P; Owen C; Zoumpourlis V; Garrett MD; Pintzas A Biochem J; 2002 Mar; 362(Pt 2):305-15. PubMed ID: 11853538 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase. Bedecs K; Elbaz N; Sutren M; Masson M; Susini C; Strosberg AD; Nahmias C Biochem J; 1997 Jul; 325 ( Pt 2)(Pt 2):449-54. PubMed ID: 9230127 [TBL] [Abstract][Full Text] [Related]
19. Activation of the mitogen-activated protein kinase pathway in U937 leukemic cells induces phosphorylation of the amino terminus of the TATA-binding protein. Biggs JR; Ahn NG; Kraft AS Cell Growth Differ; 1998 Aug; 9(8):667-76. PubMed ID: 9716183 [TBL] [Abstract][Full Text] [Related]